Theravance Biopharma, Inc. (TBPH)
SEC filings, insider trading & institutional ownership from EDGAR.
Couldn’t find the data you were looking for?
We haven’t added Theravance Biopharma, Inc.’s filings yet. We add companies and filings all the time.
Track TBPH and we’ll email you the moment its filings are in, free and with no account. Or create a free account to request coverage.
Latest filings
10-K, 10-Q, 8-K, Form 4 & 13D/G. Sourced directly from SEC EDGAR
No filings are available yet.
Top holders
13F & 13D/G • latest quarter
| Holder | Filed | Value |
|---|---|---|
| BlackRock, Inc. | Aug 7, 2026 | $77.56M |
| Vanguard Capital Management | Aug 13, 2026 | $30.12M |
| STATE STREET CORPORATION | Sep 22, 2026 | $22.59M |
| TWO SIGMA INVESTMENTS, LP | Aug 14, 2026 | $20.83M |
| D. E. Shaw & Co., Inc. | Aug 14, 2026 | $20.15M |
TBPH's filings are public. The insight is one click away.
Scrutar's AI reads every TBPH filing and points out what matters. Red flags, risk shifts, disclosure quality and key relationships. Cited to the source, free with an account.
Never miss a TBPH filing.
Get an email when TBPH files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Data as of Nov 8, 2026Source: SEC EDGAR.